London: Pfizer recently achieved a significant legal victory by winning bid in a London court to invalidate two patents held ...

Curve Therapeutics ("Curve" or the "Company"), a private biotechnology company pioneering a revolutionary intracellular screening ...

The regulatory clearance for Alembic Pharma's Gujarat facility came without any observations. The USFDA had inspected the ...

This report highlights major developments in the health sector, including WeightWatchers offering a new obesity drug, Danco ...

GSK announced on Tuesday that a single dose of its Arexvy vaccine against respiratory syncytial virus (RSV) was 43.3% ...

GlaxoSmithKline Pharma, celebrating 100 years in India, is shifting to a specialty-focused model by entering the oncology ...

Global Heparin Market was valued at US$ 10.76 billion in 2023 and is projected to surpass a valuation of US$ 15.58 billion by 2032 at a CAGR of 4.2% during the forecast period 2024–2032.

CureVac N.V. recently secured a significant deal with GSK, boosting its cash reserves. Learn more about CVAC stock and the ...

Responding to growing pressure, ViiV Healthcare announced steps to widen access to its HIV prevention medicine in low- and ...

Faced with a moribund share sale outlook and emboldened by their growing recognition on the global stage, some Chinese ...

GSK said a dose of its RSV vaccine protected against illness over three years, according to new data presented at the CHEST ...

In the late 1990s, the FDA expressed concerns regarding the diminishing potency of Merck & Co., Inc.’s (NYSE:MRK) mumps ...